Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3742649017 | Selegiline only product in transdermal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3742650017 | Product containing only selegiline in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Selegiline only product in transdermal dose form | Is a | Selegiline only product | true | Inferred relationship | Some | ||
Selegiline only product in transdermal dose form | Has manufactured dose form | Transdermal dose form | true | Inferred relationship | Some | ||
Selegiline only product in transdermal dose form | Is a | Selegiline-containing product in transdermal dose form | true | Inferred relationship | Some | ||
Selegiline only product in transdermal dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Selegiline only product in transdermal dose form | Has active ingredient | Selegiline | true | Inferred relationship | Some | 1 | |
Selegiline only product in transdermal dose form | Plays role | Antidepressant therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Selegiline 250 microgram/hour prolonged-release transdermal patch | Is a | True | Selegiline only product in transdermal dose form | Inferred relationship | Some | |
Selegiline 500 microgram/hour prolonged-release transdermal patch | Is a | True | Selegiline only product in transdermal dose form | Inferred relationship | Some | |
Selegiline 375 microgram/hour prolonged-release transdermal patch | Is a | True | Selegiline only product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets